Search Within

Maria Michelle Rubinstein

  1. "Population Sciences Research Program"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (8)
  3. Review (1)
Groups
  1. Department of Medicine (17)
  2. GDMT, Medicine (17)
  3. Gynecologic Medicine Service (17)
  4. Gynecology Disease Management Team (17)
  5. Population Sciences Research Program (17)
  6. Solid Tumor Oncology Division (17)

More Groups

People
  1. Vicky Makker (15)
  2. Carol Aghajanian (12)
  3. Britta Weigelt (10)
  4. Angela Green (9)
  5. Nadeem Abu-Rustum (8)
  6. Claire Friedman (7)

More People

Years
  1. 2025 (3)
  2. 2024 (2)
  3. 2023 (5)
  4. 2022 (4)
  5. 2021 (1)
  6. 2020 (1)

More Years

Publications
  1. Gynecologic Oncology (6)
  2. International Journal of Gynecological Cancer (3)
  3. Journal of Clinical Oncology (3)
  4. Clinical Cancer Research (2)
  5. British Journal of Cancer (1)
  6. JNCI: Journal of the National Cancer Institute (1)

More Publications

Publishers
  1. Elsevier Inc. (6)
  2. American Society of Clinical Oncology (3)
  3. Lippincott Williams & Wilkins (3)
  4. American Association for Cancer Research (2)
  5. Biomed Central Ltd (1)
  6. Nature Publishing Group (1)

More Publishers

Results (17)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real-world experience and common adverse events when using combination lenvatinib and pembrolizumab for the treatment of recurrent uterine cancer
    Meeting Abstract

    Zammarrelli, W.; Espino, K.; Yeoshoua, E.; Ehmann, S.; Rubinstein, M.; Green, A.; Makker, V.
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Germline pathogenic variants in DNA repair genes and endometrial cancer risk
    Meeting Abstract

    Gordhandas, S.; Rios-Doria, E.; Cadoo, K.; Catchings, A.; Maio, A.; Kemel, Y.; Manning-Geist, B.; Sia, T.; Roche, K. L.; Leitao, M.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • A phase II trial of IDO-inhibitor, BMS-986205 (IDO), and PD-1 inhibitor, nivolumab (NIVO), in recurrent or persistent endometrial cancer (EC; CA017-056)
    Meeting Abstract

    Kyi, C.; Rubinstein, M. M.; Shah, P.; Zhou, Q.; Iasonos, A.; Liu, Y.; Ramirez, L.; Paroder, V.; Green, A.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Microsatellite instability-high endometrial cancers with MLH1 promoter hypermethylation have distinct molecular and clinical profiles
    Journal Article

    Manning-Geist, B. L.; Liu, Y. L.; Devereaux, K. A.; Da Cruz Paula, A.; Zhou, Q. C.; Ma, W.; Selenica, P.; Ceyhan-Birsoy, O.; Moukarzel, L. A.; Hoang, T.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Targeting obesity-related dysfunction in hormonally driven cancers
    Review

    Rubinstein, M. M.; Brown, K. A.; Iyengar, N. M.
    British Journal of Cancer (2021)

    Fulltext@MSK | Save
  • Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer
    Journal Article

    Stasenko, M.; Tunnage, I.; Ashley, C. W.; Rubinstein, M. M.; Latham, A. J.; Da Cruz Paula, A.; Mueller, J. J.; Leitao, M. M. Jr; Friedman, C. F.; Makker, V.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • The prognostic significance of white adipose tissue inflammation in advanced-stage, high-grade, and serous endometrial cancers
    Meeting Abstract

    Broach, V.; Iyengar, N. M.; Zhou, X. K.; Wang, H.; Giri, D. D.; Williams, S.; Abu-Rustum, N.; Rubinstein, M. M.; Dannenberg, A. J.; Makker, V.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save